Sms Pharmaceuticals Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sms Pharmaceuticals Limited with three other
companies in this sector in India:
Shilpa Medicare Limited
sales of 7.79 billion Indian Rupees [US$121.12 million]
of which 51%
Advanced Enzyme Technologies Ltd
(3.31 billion Indian Rupees [US$51.53 million]
Ttk Healthcare Limited
(5.33 billion Indian Rupees [US$82.84 million]
of which 52%
Sms Pharmaceuticals Limited reported sales of 6.54 billion Indian Rupees (US$101.66 million)
March of 2017.
increase of 8.4%
versus 2016, when the company's sales were 6.03 billion Indian Rupees.
Sales at Sms Pharmaceuticals Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 213%).